Cohen Veterans Bioscience

What Cohen Veterans Bioscience does

Cohen Veterans Bioscience (CVB) is a non-profit 501(c)(3) biomedical research and technology organization founded in 2015 and headquartered in Cambridge, Massachusetts. The organization is dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics for post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI), with a primary focus on Veterans, active-duty service members, first responders, and civilians affected by brain trauma. CVB operates on a team-science model, convening academic researchers, federal agencies, industry partners, and patient communities to address the absence of objective diagnostic tools and FDA-approved treatments for these conditions.

The company's core technology centers on an integrated portfolio of proprietary research platforms: BRAINCommons (collaborative data analytics infrastructure), EarlySignal (wearable/sensor data collection and analysis), RAPID-Dx (biomarker discovery and validation), AMP-IT-UP (preclinical modeling), the Normative Neuroimaging Library (a standardized MRI reference database of nearly 1,900 healthy adults), and the Sleepwell digital health platform. Major research programs include the BEST Study with Stanford University (neural signature biomarkers for PTSD treatment matching), the Global PTSD Genetics Study (200+ researchers across 12 countries, 200,000+ individuals, 95 identified risk loci), and standards-setting initiatives including the CDISC PTSD Therapeutic Area User Guide and preclinical common data elements for TBI.

CVB's business model is donation and grant-driven rather than commercial. Revenue is derived from charitable contributions from individuals, foundations, and corporations, federal research grants (including NIH and BRAIN Initiative funding), and fiscal sponsorship fees for initiatives such as the Global Preclinical Data Forum and the Guarantors of EQIPD. The organization maintains a small core team and relies on advocacy-driven funding, technology partnerships with firms like Siemens Healthineers, and a Veterans Advisory Council to advance its research agenda. Recent leadership changes saw founder Magali Haas, MD/PhD transition to a Senior Advisor role after 12 years, with Peter Hoehn, JD appointed as CEO.

Name

Cohen Veterans Bioscience

Legal name

Cohen Veterans Bioscience

Website

https://cohenveteransbioscience.org

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1–10 employees

Short description

Cohen Veterans Bioscience is a non-profit 501(c)(3) biomedical research organization that fast-tracks precision diagnostics and therapeutics for PTSD and TBI, serving Veterans, service members, first responders, and civilians through proprietary research platforms and global research consortia.

Ownership category

akta.pro rank

Product category

Biomedical Research

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Voluntary Health Organizations (813212)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)

akta.pro primary industry

Behavioral Health & Neurocognitive Therapeutics (Digital) (HLACANAI)

akta.pro secondary industry

Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)

Keywords

• Biomedical research
• Brain trauma therapeutics
• PTSD diagnostics
• Traumatic brain injury
• Neuroscience data platform

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Donations and Charitable Contributions: As a non-profit 501(c)(3) biomedical research organization, CVB relies primarily on donations from individuals, foundations, and corporations to fund its research programs and operational activities.
2. Federal Research Grants and Advocacy-Driven Funding: CVB advocates for and secures federal funding for brain trauma research, including NIH and BRAIN Initiative grants. Its advocacy efforts seek sustainable and predictable growth of NIH budget and targeted funding for brain trauma-related disorders commensurate with disease burden.
3. Fiscal Sponsorship Revenue: CVB serves as fiscal sponsor for initiatives including the Global Preclinical Data Forum (GPDF) and the Guarantors of EQIPD, providing administrative and organizational support that may include funding management.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Core offering

Cohen Veterans Bioscience is a nonprofit biomedical research organization that develops and operates proprietary data and diagnostic platforms to accelerate discovery of diagnostics and therapeutics for brain trauma, including PTSD and traumatic brain injury (TBI). It runs flagship translational research programs and partners with academic, government, and industry stakeholders to advance precision-medicine approaches to brain trauma.

Product overview

Cohen Veterans Bioscience operates as a non-profit biomedical research and technology organization offering an integrated portfolio of research platforms, digital health solutions, and research programs focused on brain trauma diagnostics and therapeutics. The product portfolio centers on four core platforms: BRAINCommons (collaborative research infrastructure), EarlySignal/EaSi (wearable sensor data collection), RAPID-Dx (biomarker discovery), and AMP-IT-UP (preclinical modeling). These are complemented by major research initiatives including the Normative Neuroimaging Library (NNL), BEST Study (neural signature biomarkers), Global PTSD Genetics Study, and Sleepwell digital health program. The organization also provides research standardization tools (CDISC standards, PEERS database, GPDF community) and community initiatives (TBI Action Alliance, Coalition to Heal Invisible Wounds) to accelerate precision diagnostics and tailored therapeutics for PTSD and TBI.

Differentiator

Problem solved

Functional benefit

Brands

• Brain Trauma Blueprint: Research framework for advancing solutions for brain trauma
• TBI Action Alliance
• TBI Trailblazers Volunteer Network
• BRAINCommons
• EarlySignal (EaSi)
• RAPID-Dx
• AMP-IT-UP
• Sleepwell
• Best PTSD Study
• Normative Neuroimaging Library (NNL)
• Global PTSD Genetics Study
• Global Preclinical Data Forum
• PEERS
• EQIPD
• Coalition to Heal Invisible Wounds

Products and services

• BRAINCommons
• EarlySignal Biomarker-based screening platform for PTSD and related neuropsychiatric conditions enabling objective measurement to complement subjective clinical assessments.
• RAPID-Dx In-vitro diagnostic development program for rapid detection and stratification of TBI and PTSD using blood-based and other molecular biomarkers.
• AMP-IT-UP Predictive drug repurposing platform that uses computational models and existing data to identify candidate therapeutics for PTSD and other trauma-related conditions.
• BEST Study Multi-site translational research study exploring biomarkers and clinical endpoints for brain trauma conditions including PTSD and TBI.
• Global PTSD Genetics Study Large-scale genetics study focused on identifying genetic variants and biological pathways associated with PTSD susceptibility, progression, and treatment response.
• NeuroNova Lab (NNL) Community-facing innovation lab that crowdsources and incubates ideas for brain trauma and veteran health challenges, engaging researchers, clinicians, and the public.
• Sleepwell Research program examining sleep apnea and related sleep comorbidities in veteran and trauma populations and their relationship to brain trauma outcomes.

Quantifiable outcome

• PTSD patient stratification based on blood flow changes correlating with response to prolonged exposure psychotherapy, moving diagnosis from symptoms-based to biologically-based approach
• +3 more outcomes

Named customers7 records

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature12 records

Partnerships

13 partnerships are on record, tiered core, secondary and minor.

• Siemens HealthineerscoreStrategic or Co-development Partner · 11 November 2025Siemens Healthineers and CVB announced a landmark collaboration to enhance the National Normative Neuroimaging Library (NNL) with advanced blood-based biomarker data. The NNL contains brain imaging and clinical data from nearly 1,900 healthy adults. This integration creates the first multimodal normative reference standard for brain health research, linking Siemens Healthineers' biomarker assay data with existing imaging and clinical measures to accelerate diagnostic precision and therapeutic development for brain disorders.
• Stanford UniversitycoreStrategic or Co-development PartnerCVB partnered with Stanford University researchers (led by Dr. Amit Etkin) on the BEST (Biomarker Establishment for Superior Treatment of PTSD) Study, examining clinical biomarkers to identify brain activity patterns and neural signatures in PTSD within a large Veteran population. Results demonstrated that PTSD patients could be stratified into groups based on changes in blood flow correlating with response to psychotherapy.
• Academic Medical Centers (NNL)coreStrategic or Co-development PartnerThe National Normative Neuroimaging Library (NNL) was established with leading academic centers including the University of Virginia (Dr. James R. Stone, Principal Investigator, Vice Chair of Research, UVA Department of Radiology and Medical Imaging). The NNL performs standardized MRI scans on healthy adult volunteers to create a reference database for diagnosing conditions resulting from subtle brain changes.
• Global PTSD Genetics PartnershipcoreStrategic or Co-development PartnerCVB coordinated the Global PTSD Genetics Study with more than 200 researchers across 12 countries analyzing genetic data from over 200,000 individuals, demonstrating that PTSD risk is heritable (5-20%) with findings published in Nature Genetics (2024) identifying 95 risk loci. Partners include the Broad Institute and Harvard T.H. Chan School of Public Health (led by Dr. Karestan C. Koenen).
• The Michael J. Fox Foundation for Parkinson's ResearchsecondaryStrategic or Co-development PartnerCVB partners with The Michael J. Fox Foundation on the Parkinson’s Progression Markers Initiative (PPMI), with CVB’s data science team quantitatively exploring, evaluating, and predicting disease trajectory and risk factors using PPMI data to support development of new therapies for clinical trials. CVB’s Todd Sherer serves on the BRAINCommons advisory board.
• Veterans Health Administration (VHA)coreStrategic or Co-development PartnerRachel Ramoni, DMD, ScD, Chief Research and Development Officer at VHA, has publicly endorsed CVB’s team science approach and coordination model as the fastest way to help Veterans with TBI and PTSD. VHA represents the largest integrated healthcare system serving Veterans and is a key research and clinical partner in brain trauma research.
• University of Pennsylvania (Sleep Research Team)secondaryStrategic or Co-development PartnerCVB partnered with a leading sleep research team at the University of Pennsylvania for the Technical Performance Verification Study, comparing accuracy of six wearable and home sensor devices against polysomnography (PSG) gold standard in people with insomnia and PTSD, to determine which devices best capture sleep data.
• Clinical Data Interchange Standards Consortium (CDISC)secondaryStrategic or Co-development PartnerCVB partnered with CDISC to publish the first Therapeutic Area (TA) Standard for PTSD (v1.0), establishing how data should be recorded in standardized databases and best practices across the clinical research industry for recording, reporting, and sharing PTSD-specific data to facilitate regulatory submissions.
• National Institute of Neurological Disorders and Stroke (NINDS)secondaryStrategic or Co-development PartnerCVB scientific team members participated in a committee of experts working with NINDS to develop Common Data Elements (CDEs) for preclinical TBI research, enabling big data approaches by providing consistency in the way data is collected, formatted, and described across studies.
• Global Preclinical Data Forum (GPDF)secondaryStrategic or Co-development PartnerCVB is the fiscal sponsor of the Global Preclinical Data Forum (GPDF), a U.S. and European jointly-sponsored initiative encouraging global collaboration to address reproducibility, robustness, and translatability of preclinical research. CVB is part of the GPDF leadership Core Team.
• EQIPD / Guarantors of EQIPDminorStrategic or Co-development PartnerCVB is a fiscal sponsor of the Guarantors of EQIPD, which disseminates strategies developed by the original EQIPD consortium (2017-2021) of over 20 research groups from industry and academia to reduce risk in drug development research and ensure rigorous research practices.
• NIH BRAIN InitiativesecondaryStrategic or Co-development PartnerCVB supports robust and continued funding for the NIH BRAIN Initiative and advocates for all BRAIN Initiative data to be made openly accessible to the scientific community to advance progress in brain science and brain trauma research.
• Coalition to Heal Invisible WoundssecondaryStrategic or Co-development PartnerCVB co-founded the Coalition to Heal Invisible Wounds, which brings together leading nonprofit organizations seeking to advance a comprehensive research-focused advocacy agenda to address PTSD, TBI, and co-morbid conditions such as pain and substance use disorders that increase suicide risk among Veterans and service members.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• The Michael J. Fox Foundation for Parkinson's Research: Disease-specific 501(c)(3) research nonprofit that has built large-scale biomarker datasets (e.g., PPMI), funds neuroscience R&D, and partners with industry — explicitly named as a CVB partner on the PPMI data science collaboration, making it the most structurally analogous peer.
• Cohen Veterans Network: Sister Steven Cohen-family initiative providing mental-health clinical services to veterans through a network of centers — directly comparable mission focus on veteran brain health while complementing CVB's research-and-platform role with service delivery.
• One Mind: Brain-health-focused 501(c)(3) that accelerates research and cures through industry and academic collaboration, mirroring CVB's team-science model, partnership-heavy GTM, and platform-driven value proposition.
• Henry M. Jackson Foundation for the Advancement of Military Medicine: Nonprofit that funds and manages military medical research at Uniformed Services University, sharing CVB's military-and-veteran patient focus and reliance on federally-advocated research funding.
• Brain & Behavior Research Foundation: Nonprofit that funds and disseminates brain and behavioral research (including PTSD) through grants and awards, employing the same 501(c)(3) donation-and-grant model as CVB with overlapping scientific mission.

Broad incumbents

• ALS Association: Large disease-specific research and advocacy nonprofit that has built coordinated research networks, biomarker initiatives, and federal advocacy capacity — a structurally comparable nonprofit research model in a different disease vertical.
• Wounded Warrior Project: Large veterans-services nonprofit with broad programming including mental health and brain-injury support — overlaps CVB's target beneficiary population while pursuing a much wider service portfolio.
• American Foundation for Suicide Prevention: Large, established nonprofit addressing the suicide-prevention problem that CVB's brain-trauma research targets (17.5 Veteran suicides/day), serving a similar donor base and overlapping policy-advocacy agenda, but operating at a much larger fundraising scale.

Others

• Uniformed Services University of the Health Sciences: Federal military medical education and research university that, alongside HJF, conducts much of the federally-funded military-medicine and TBI/PTSD research that CVB's platforms aim to enable — adjacent ecosystem participant rather than a direct competitor.

Emerging players

• CURE (Citizens United for Research in Epilepsy): Smaller disease-specific research nonprofit employing a similar model of funding research, advancing federal advocacy, and convening scientific communities — comparable in scale and operating philosophy to CVB but focused on epilepsy rather than brain trauma.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/cohenbioscience
• Facebookfacebook.com/277199655782980
• LinkedInlinkedin.com/company/cohen-veterans-bioscience

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cohen Veterans Bioscience